Use of drugs in the treatment of obesity

被引:17
作者
Atkinson, RL [1 ]
机构
[1] UNIV WISCONSIN,DEPT NUTR SCI,MADISON,WI 53706
关键词
medications; co-morbidities; adverse events;
D O I
10.1146/annurev.nutr.17.1.383
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Obesity has become an epidemic in the United States and in many other countries of the world. Obesity is a chronic disease, not a failure of willpower. Diet, exercise, and behavioral modification of lifestyle are rarely successful over the long term. Medications have been used sparingly, because of concerns about addiction and ineffectiveness, but used chronically, obesity drugs are effective. The two main categories of obesity drugs are centrally active adrenergic and serotonergic agents. These drugs reduce appetite, enhance satiety, and increase energy expenditure. Use of single agents produces modest weight loss and use of combinations increases loss, but few patients reach their goal weight. Co-morbidities associated with obesity resolve or are reduced in severity with weight loss. Adverse events of major concern are changes in brain biochemistry and primary pulmonary hypertension. Published guidelines for use of obesity medications recommend they be used only for medically significant obesity.
引用
收藏
页码:383 / 403
页数:21
相关论文
共 77 条
  • [1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension
    Abenhaim, L
    Moride, Y
    Brenot, F
    Rich, S
    Benichou, J
    Kurz, X
    Higenbottam, T
    Oakley, C
    Wouters, E
    Aubier, M
    Simonneau, G
    Begaud, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) : 609 - 616
  • [2] *AM OB ASS, 1996, GUID TREATM ADULT OB
  • [3] ANDERSEN T, 1988, INT J OBESITY, V12, P277
  • [4] ATKINSON RL, 1996, PROGR OBESITY RES, V7
  • [5] ATKINSON RL, 1995, OBES RES S4, V3, P497
  • [6] BAEZ M, 1995, OBES RES S4, V3, P441
  • [8] BLUNDELL JE, 1995, OBES RES, V3, P471
  • [9] DIETARY-FAT AFFECTS WEIGHT-LOSS AND ADIPOSITY DURING ENERGY RESTRICTION IN RATS
    BOOZER, CN
    BRASSEUR, A
    ATKINSON, RL
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1993, 58 (06) : 846 - 852
  • [10] BOOZER CN, 1995, AM J PHYSIOL-ENDOC M, V268, pE546